FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3715711000001101: Franol tablets (Sanofi-Synthelabo Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17634501000001117 Franol tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66020501000001111 Franol tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Franol tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Is a Product containing precisely ephedrine hydrochloride 11 milligram and theophylline 120 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has active ingredient Xanthine false Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has active ingredient Theophylline false Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has active ingredient Smooth muscle relaxant false Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has active ingredient Ephedrine hydrochloride false Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Is a Franol true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Ephedrine hydrochloride true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Theophylline true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Franol tablets (Sanofi-Synthelabo Ltd) 90 tablet Is pack of False Franol tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Franol tablets (Sanofi-Synthelabo Ltd) 90 tablet Has AMP True Franol tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start